Conning Inc’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.8M Sell
384,661
-42,092
-10% -$3.75M 1.09% 56
2025
Q4
$33.7M Buy
426,753
+39,655
+10% +$3.11M 1.13% 24
2025
Q3
$30.9M Buy
387,098
+11,075
+3% +$945K 1.03% 57
2025
Q2
$34.2M Sell
376,023
-4,538
-1% -$414K 1.17% 42
2025
Q1
$35.7M Sell
380,561
-10,456
-3% -$936K 1.25% 28
2024
Q4
$35.5M Buy
391,017
+45,281
+13% +$4.32M 1.25% 30
2024
Q3
$35.9M Sell
345,736
-36,591
-10% -$3.73M 1.19% 52
2024
Q2
$37M Sell
382,327
-30,463
-7% -$2.81M 1.33% 13
2024
Q1
$37.1M Buy
412,790
+11,497
+3% +$974K 1.22% 43
2023
Q4
$31.9M Sell
401,293
-60,809
-13% -$4.57M 1.11% 48
2023
Q3
$32.8M Buy
462,102
+14,591
+3% +$1.09M 1.2% 41
2023
Q2
$34.4M Sell
447,511
-29,076
-6% -$2.25M 1.15% 49
2023
Q1
$35.8M Buy
476,587
+17,301
+4% +$1.29M 1.2% 36
2022
Q4
$36.1M Buy
459,286
+11,133
+2% +$835K 1.17% 30
2022
Q3
$31.5M Sell
448,153
-27,913
-6% -$2.19M 1.12% 42
2022
Q2
$38.1M Sell
476,066
-21,103
-4% -$1.65M 1.14% 40
2022
Q1
$37.7M Sell
497,169
-45,474
-8% -$3.6M 1.03% 53
2021
Q4
$46.3M Buy
542,643
+4,613
+0.9% +$360K 1.23% 40
2021
Q3
$40.6M Buy
538,030
+24,886
+5% +$1.98M 1.17% 44
2021
Q2
$41.7M Sell
513,144
-22,170
-4% -$1.81M 1.21% 45
2021
Q1
$42.2M Buy
535,314
+70,566
+15% +$5.53M 1.27% 46
2020
Q4
$39.7M Sell
464,748
-14,527
-3% -$1.2M 1.26% 42
2020
Q3
$37M Sell
479,275
-3,009
-0.6% -$229K 1.3% 39
2020
Q2
$35.3M Buy
482,284
+469,070
+3,550% +$33.3M 1.31% 38
2020
Q1
$877K Sell
13,214
-470
-3% -$33.1K 0.04% 188
2019
Q4
$942K Sell
13,684
-1,020
-7% -$69.5K 0.03% 209
2019
Q3
$1.08M Sell
14,704
-1,550
-10% -$112K 0.04% 206
2019
Q2
$1.17M Sell
16,254
-3,306
-17% -$235K 0.04% 204
2019
Q1
$1.34M Sell
19,560
-290
-1% -$18.7K 0.04% 216
2018
Q4
$1.18M Sell
19,850
-2,280
-10% -$143K 0.04% 216
2018
Q3
$1.48M Sell
22,130
-1,110
-5% -$73.9K 0.04% 220
2018
Q2
$1.51M Sell
23,240
-610
-3% -$39.9K 0.05% 233
2018
Q1
$1.71M Sell
23,850
-310
-1% -$22.3K 0.06% 201
2017
Q4
$1.82M Sell
24,160
-100
-0.4% -$7.3K 0.06% 197
2017
Q3
$1.77M Sell
24,260
-240
-1% -$17.3K 0.06% 206
2017
Q2
$1.82M Sell
24,500
-476
-2% -$35.3K 0.07% 200
2017
Q1
$1.83M Sell
24,976
-870
-3% -$60.9K 0.07% 191
2016
Q4
$1.69M Buy
25,846
+690
+3% +$47.3K 0.07% 203
2016
Q3
$1.86M Buy
25,156
+1,130
+5% +$83.5K 0.07% 190
2016
Q2
$1.76M Buy
24,026
+900
+4% +$64.1K 0.07% 200
2016
Q1
$1.63M Buy
23,126
+720
+3% +$47.9K 0.07% 204
2015
Q4
$1.49M Sell
22,406
-670
-3% -$44.6K 0.06% 205
2015
Q3
$1.46M Sell
23,076
-3,755
-14% -$245K 0.06% 197
2015
Q2
$1.75M Sell
26,831
-332,081
-93% -$22.5M 0.07% 189
2015
Q1
$24.9M Buy
358,912
+54,508
+18% +$3.77M 1.06% 43
2014
Q4
$21.1M Sell
304,404
-90
-0% -$6.08K 1.03% 40
2014
Q3
$19.9M Buy
304,494
+30,092
+11% +$1.98M 1.04% 39
2014
Q2
$18.7M Sell
274,402
-1,076
-0.4% -$72.1K 0.99% 36
2014
Q1
$17.9M Buy
275,478
+19,305
+8% +$1.22M 1.05% 30
2013
Q4
$16.7M Buy
256,173
+45,586
+22% +$2.92M 1.04% 34
2013
Q3
$12.5M Buy
210,587
+3,367
+2% +$199K 0.96% 36
2013
Q2
$11.9M Buy
+207,220
New +$12.3M 0.98% 35

Other funds holding CL

Conning Inc's CL Position: Q1 2026 in Review

Conning Inc reduced its Colgate-Palmolive (CL) stake by 9.9% in Q1 2026, selling an estimated $3.75M and leaving 384,661 shares worth $32.8M. The position accounts for 1.09% of the portfolio, ranked #56.

Conning Inc first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.3M in Q4 2021. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Conning Inc held 384,661 shares of Colgate-Palmolive worth $32.8M as of Q1 2026.
  • Conning Inc sold 42,092 Colgate-Palmolive shares in Q1 2026, an estimated $3.75M.
  • Colgate-Palmolive made up 1.09% of Conning Inc's portfolio in Q1 2026, its #56 holding.
  • Conning Inc first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Conning Inc's Colgate-Palmolive position peaked at $46.3M in Q4 2021.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Conning Inc's 13F filing for Q1 2026, filed 30 Apr 2026.